Provence Wealth Management Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$1.63M Buy
2,801
+415
+17% +$242K 0.88% 30
2023
Q3
$1.28M Buy
2,386
+223
+10% +$115K 0.79% 31
2023
Q2
$1.01M Buy
2,163
+330
+18% +$138K 0.6% 35
2023
Q1
$629K Buy
1,833
+419
+30% +$141K 0.42% 53
2022
Q4
$517K Buy
+1,414
New +$501K 0.42% 55

Other funds holding LLY

Provence Wealth Management Group's LLY Position: Q4 2023 in Review

Provence Wealth Management Group increased its Eli Lilly (LLY) stake by 17% in Q4 2023, buying an estimated $242K and bringing the position to 2,801 shares worth $1.63M. The position accounts for 0.88% of the portfolio, ranked #30.

Provence Wealth Management Group first reported a position in LLY in Q4 2022 and has held it in 5 quarters since. 3,274 funds tracked by Wall St. Rank hold LLY as of Q4 2023.

  • Provence Wealth Management Group held 2,801 shares of Eli Lilly worth $1.63M as of Q4 2023.
  • Provence Wealth Management Group bought 415 Eli Lilly shares in Q4 2023, an estimated $242K.
  • Eli Lilly made up 0.88% of Provence Wealth Management Group's portfolio in Q4 2023, its #30 holding.
  • Provence Wealth Management Group first reported a position in Eli Lilly in Q4 2022 and has held it in 5 quarters since.
  • 3,274 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.

Based on Provence Wealth Management Group's 13F filing for Q4 2023, filed 6 Feb 2024.